Auburndale, MA, United States of America

Tadeas Liska

This inventor holds 1 USPTO granted patent. Top assignee: Kala Pharmaceuticals, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadeas Liska. Retrieved from https://idiyas.com/inventor/tadeas-liska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Of course! Here's an article about the inventor Tadeas Liska:

Title: Unveiling Inventor Tadeas Liska: Revolutionizing Therapeutic Compounds in Auburndale, MA

Introduction:

Tadeas Liska, a pioneering inventor hailing from Auburndale, MA, has left an indelible mark in the field of pharmaceuticals through his groundbreaking discoveries and patents.

Latest Patents:

With a keen focus on innovation, Liska's most recent patent titled "Crystalline forms of a therapeutic compound and uses thereof" showcases his expertise in developing novel crystalline forms of Compound 5 for the treatment of various diseases associated with abnormal angiogenesis and growth factor signaling pathways.

Career Highlights:

Currently affiliated with Kala Pharmaceuticals, Inc., Tadeas Liska has seamlessly integrated his inventiveness with the dynamic research environment of the company, thereby contributing significantly to advancements in pharmaceutical sciences.

Collaborations:

Collaborating with accomplished professionals like Elizabeth M Enlow and Jinsoo Kim, Liska has fostered a culture of innovation and collaboration, bringing together diverse expertise to tackle complex medical challenges.

Conclusion:

In conclusion, Tadeas Liska stands as a testament to the power of ingenuity and perseverance in the realm of pharmaceutical inventions. His contributions not only enrich the scientific community but also hold promise for a brighter future in the realm of healthcare innovation.

Let me know if you need further information or assistance!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…